Annual revenue of 2 billion | so a medical device supplier should actually come to the new three!

Medical equipment and a new generation of information technology, high-end CNC machine tools and robots, energy-saving and new, in the "China-made 2025", medical equipment and a new generation of information technology, high-end CNC machine tools and robots, energy-saving and new Energy vehicles together as one of the top ten key areas.At the same time, with the economic development, population aging and the increasing awareness of the people's health care, China's medical equipment also presents a huge market demand.

Now, there is such a medical equipment provider, backed by the Shanghai SASAC's Oriental Start a business (600,278), through the procurement of medical equipment for domestic distribution and to provide medical equipment to customers proxy Import services, last year to create a net profit of more than 85 million yuan.

This company is Shanghai Dongsong Medical Technology Co., Ltd. (Dongsong Medical). Recently, Dongsong Medical's revitalization book appeared in the pending information of the stock transfer company, which means that this company has a strong State-owned background medical instruments Company, has embarked on the road to the new board.

Founded in 1997, Dongsong Medical, formerly known as Shanghai Dongsong International Trade Co., Ltd., relies on the tree owned by Shanghai SASAC. After 20 years of hard work, Dongsong Medical has enjoyed some competitive advantages in Shanghai.

Dongsong medical main business, to provide medical equipment agent import services, bidding agency business and medical equipment channel management business.

Because in the medical device industry, the manufacturer is very professional in product R & D, production, quality, inspection and other aspects, but the sales are usually lack of a sound sales network, while lack of understanding of the market for competitive products and research.Many of the distributors Also do not want to get goods directly from the manufacturers, on the one hand is the manufacturer of the dealer has the purchase volume requirements, if the purchase amount is small, there is no price advantage.

At this time, the distributor as a bridge between the manufacturer and the dealer has a bearing on the medical device platform.On the one hand, due to a large amount of purchase can enjoy more preferential policies, as manufacturers let the distributor, So dealers can enjoy the ex-factory price of the same price policy.On the other hand, manufacturers are responsible for the dealer is only responsible for payment, delivery, do not spend more energy and the team to care about how dealers sell or how to better Sales.

At present, Beijing, Shanghai and Guangdong are leading the bidding and purchasing of medical equipment. The three provinces and municipalities together account for about 76% of the market share. Among them, Shanghai ranks the first place among the provinces, autonomous regions and municipalities.

Public transfer manual shows that Dongsong medical agent in Shanghai, the largest medical equipment bidding business, which commissioned clients include Shanghai Public hospital And major foreign investment, private medical institutions, etc. From January to July 2017, the top five clients of Dongsong Medical were Shanghai First People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Chest Hospital, Shanghai Sixth People Hospital, Zhongshan Hospital Affiliated to Fudan University.

For its own advantages, Dong Song Medical said the company after 20 years focused on the development of medical equipment and related business development, accumulated a large number of large areas of health resources, through the advantages of resources, the company more likely to obtain high-end medical products priority operating qualifications, and And all levels of medical institutions, research institutions, universities and other downstream distribution companies and other end users to establish long-term and stable relations of cooperation.

This advantage is also reflected in the performance, 2015, 2016, 2017 January-July, Dongsong medical revenue of 2.819 billion yuan, respectively, 1.987 billion yuan, 10.59 billion yuan, the net profit was 63.9982 million Yuan, 85.325 million yuan, 4360.71 million yuan.

In contrast, in 2016, Dongsong Medical's net profit in the new three boards, second only to the same industry boss Tianshi Marketing (872087) 93,376,900 yuan, far more than the new three board medical supplies and equipment wholesale industry average of 9.8901 million yuan value.

Data show that by 2020, China will be an annual increase of nearly 6 million elderly population, due to the consumption of medical expenses in the elderly 3-5 times the young people, medical equipment market demand will continue in the next period of time high-speed growth trend.

At the same time, as urban life accelerates and national healthcare awareness continues to increase, more and more patient groups choose to use the various household medical products for continuous treatment after discharge, and home medical devices mainly for health care and conditioning And to assist in the treatment of chronic pain as the main function of the home medical supplies market prospects for the development is even more a blue ocean.

On the other hand, from a regional point of view, the new medical reform clearly pointed out that the state will gradually increase public health system and urban community and rural grass-roots medical and health construction.With the continuous deepening of the national medical reform to the countryside and the community and the second and third tier cities, The growth of consumption power in towns and towns and economically backward regions including the Midwest will bring great room for growth in the demand for medical devices in these regions in the future.

Faced with such a huge market, Dongsong medical agent bidding range is mostly confined to the Shanghai area, which also greatly limits the company's future expansion of the business scale.

In the face of this ceiling, Dongsong Medical said it will raise funds through various channels, increase the development of new business and further develop the national market.

At the same time, the company will also increase brand promotion efforts to expand enterprise Image promotion, market development and other business sectors related to the medical service industry, and continuously improve the company's brand awareness and market share in new areas.

As Dongsong Medical's main business is concentrated in Shanghai, while the business development in other regions is relatively slow, it is inevitable for Dongsong to break through the current revenue ceiling by capitalizing on the capital market and increasing its visibility. In this point of view, the new three is undoubtedly the best choice Dongsong medical treatment of pain points at this stage.